10月22日，康希诺生物盘中下跌5.12%，报28.56港元，成交额4786.78万港元。
从公开信息看，公司将于10月27日召开董事会审议第三季度业绩，市场正进入季报窗口。公司此前中期营收5.47亿元，同比增长46.1%，经调整净亏损收窄至72.10万元；10月中旬公司还披露收到286.63万元政府补助，预计对利润产生积极影响。
不过，当日生物科技板块整体偏弱，康方生物跌9.43%，信达生物跌7.86%，百济神州跌2.68%，三生制药跌4.9%，板块波动对个股形成压制。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.